Pinnacle Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230K Buy
250
+9
+4% +$9.12K 0.06% 105
2025
Q4
$259K Buy
+241
New +$230K 0.08% 99
2024
Q3
Sell
-233
Closed -$211K 83
2024
Q2
$211K Buy
+233
New +$186K 0.09% 68

Other funds holding LLY

Pinnacle Financial Group's LLY Position: Q1 2026 in Review

Pinnacle Financial Group increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $9.12K and bringing the position to 250 shares worth $230K. The position accounts for 0.06% of the portfolio, ranked #105.

Pinnacle Financial Group first reported a position in LLY in Q2 2024 and has held it in 3 quarters since. The position peaked at $259K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pinnacle Financial Group held 250 shares of Eli Lilly worth $230K as of Q1 2026.
  • Pinnacle Financial Group bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.06% of Pinnacle Financial Group's portfolio in Q1 2026, its #105 holding.
  • Pinnacle Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 3 quarters since.
  • Pinnacle Financial Group's Eli Lilly position peaked at $259K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pinnacle Financial Group's 13F filing for Q1 2026, filed 13 May 2026.